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INTRODUCTION: 
Idiopathic Bell’s palsy is the most common type of facial 
neuropathy, characterized by sudden onset of facial 
paresis/paralysis. It is common in adults and has equal 
sexual preponderance1. It leads to Lagophthalmos 
(inability to close the eyelids completely) because of 
paralysis of Orbicularis oculi muscle. Inability to close 
lids will lead to exposure of cornea, dryness and 
ulceration. Corneal ulceration will not heal with 
conventional therapy of topical antibiotic eye drops and 
cycloplegic eye drops. Options available to heal the 
ulceration of cornea are temporary taping of lids with 
usage of lubricating eye drops and gel ointment to 
protect cornea. Other option is temporary tarsorrhaphy 
using sutures. Permanent methods of managing 
Lagophthalmos like Gold plate implant in lid, Permanent 
tarsorrhaphy, LPS recession is not required as 85% of 
Bell’s palsy recovers by 8-12 weeks. 
Injection of Botulinum toxin A is used to create 
temporary ptosis which covers cornea and helps in 
healing exposure keratopathy 4, 5, 6. 
Aim:  
Is to evaluate the efficacy of chemo-denervation of LPS 
to induce temporary ptosis using injection Botulinum 
Toxin A in protecting cornea and healing exposure 
keratopathy. 
Materials and Methods:  
This is a prospective interventional study conducted at 
the department of Oculoplasty and orbital disorders of 
Sarojini Devi eye Hospital which is tertiary eye care 
centre in Hyderabad. Period of study was between June 
2010 to May 2012. 
24 cases of proven Bell’s palsy were included in the 
study.11 were males and13 were females. Permanent 
causes of facial palsy like Cerebro-pontine angle tumors, 
Hansen’s disease, Traumatic facial palsy, facial palsy 
due to CSOM, Post mastoidectomy facial palsies were 
excluded from study. Patient with known allergy to 
Botox and patient who lost to follow-up were also 
excluded from study.Informed consent was taken from 
all patients in their mother tongue. 
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ABSTRACT: 
Aim: Is to evaluate the efficacy of Chemo-denervation of LPS to induce temporary ptosis using Injection Botox in protecting 
Cornea and healing exposure keratopathy. 
Materials & Methods: Prospective interventional study conducted at Tertiary eye care centre of Hyderabad. Study period 
between June 2010 to May 2012. 24 cases of Bell’s palsy , 11 males & 13 females between age group of 20-80 years were 
included in the study. Facial palsy due to CP angle tumors, Hansen’s disease, Trauma, CSOM and post mastoidectomy were 
excluded as these are permanent causes. Patient with known allergy to Botox and patient who lost to follow up were also 
excluded. Cases included were examined by an ophthalmologist and radiologically evaluated to rule out other causes of facial 
palsy. Height of palpebral aperture, amount of Lagophthalmos, exposure keratopathy was documented. 0.25cc of injection 
Botox containing 6.25IU of Botox was injected at the insertion of LPS. Patient was examined at the end of 1st week, 2nd week, 
4th week and 8th week to check all the 3 parameters. 
Results: At the end of 1st week in 16 cases mean palpebral height of 9mm (SD +/- 1.2mm) before injection was reduced to 
2mm (SD+/- 1.0mm) after injection. At the end of 2nd week 8 cases achieved ptosis. Mean difference in Palpebral aperture 
height was 7mm (p value of 0.05) which is significant. All cases showed improvement in exposure keratopathy. 20 cases 
recovered from Bell’s palsy within 8 weeks . 4 cases required 2nd injection of Botox as ptosis started recovering but Bell’s 
palsy persists. Mean amount of Lagophthalmos of 4.3mm (SD+/- 0.7mm) before injection was reduced to 1.1mm (SD+/- 
1.0mm) at the end of 2nd week. P value of <0.05 which is significant. 
Conclusion: Inj.Botox is safe and effective method to achieve ptosis by Chemo-denervation of LPS. Action of Botox remains 
for 8 weeks wherein 85% of cases recovered from Bell’s palsy.    
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24 cases of Bell’s palsy were clinically examined by an 
experienced Ophthalmologist and radiologically 
evaluated to rule out CP angle tumour and other causes 
of facial palsy. Basic investigations like CBP, ESR, 
RBS, and CT scan Brain were carried out. Palpebral 
aperture height in primary gaze and amount of 
lagophthalmos were measured in millimeters. Exposure 
keratopathy was documented by staining cornea with 
Fluorescien sodium. 
Preparation of BOTOX: A vial containing 50 IU of 
Botulinum Toxin A is diluted by 2cc of preservative free 
distill water. 0.25 cc of injection Botox was drawn in 
tuberculin syringe which is equal to 6.25 IU. Under all 
aseptic precautions in MOT patient’s eyelid was cleaned 
by Betadine lotion and covered by sterile drape. Injection 
2% Xylocaine 0.5 cc injected sub cutaneously on tarsal 
plate to anaesthetize the lid and inj. Botox was given at 
the insertion of LPS on tarsal plate transcutaneously. 
Treatment of ulcer cornea is continued by giving topical 
antibiotic eye drops and cycloplegic eye drops. Patient 
was examined at the end of 1st week, 2nd week, 4th week 
and 8
th
 week. At every visit healing of corneal ulcer, 
height of Palpebral aperture and amount of 
lagophthalmos was noted.   
RESULTS:  
At the end of 1st week in 16 cases mean palpebral 
aperture height of 9mm (SD +/- 1.2mm) before injection 
of Botox was reduced to 2mm (SD+/- 1.0mm) showing 
the achievement of chemo-denervation. 
At the end of 2nd week remaining 8 cases developed 
ptosis. All 24 cases showed improvement in the status of 
healing of exposure keratopathy. Mean difference in 
palpebral aperture height before and after injection of 
Botox was 7mm (p value of 0.05) which is statistically 
significant. 
20 cases recovered from Bell’s palsy within 8 weeks. 4 
cases needed 2nd injection of Botox as Ptosis started 
recovering and Bell’s palsy didn’t recover. 
Mean amount of Lagophthalmos before injection of 
Botox was 4.3mm(SD+/- 0.7mm) was reduced to 1.1mm 
(SD+/- 1mm) at the end of 2nd week (p value of <0.05 
was statistically significant.
     
                                              
                                                                   Before Injection 
        
After Injection(2nd week)                                                                         After Injection(8th week) 
Figure 1: showing palpebral aperture, Lagophthalmos & Exposure keratopathy before inj. &4th week & 8th week after 
inj. of botox 
DISCUSSION:  
24 cases of Bell’s palsy of whom 11 were males and 13 
were females, between the age group of 20 to 80 were 
selected for study. Male to female percentage ratio was 
46/54 in present study which is matching with Adam et 
al study that had sex percentage ratio of 45.85/54.15 6. 
All other study injected Botox at the belly of LPS muscle 
wherein chances of globe perforation is there. In present 
study we injected Botox at the insertion of LPS on Tarsal 
plate, which totally avoided globe perforation. 
Median age of presentation in Milind Naik et al study 
was 30 years. In present study it was 40 years. Reduction 
in Mean palpebral aperture height of 9mm before 
injection to 2mm after injection in present study was 
comparable to Milind naik et al. 
Amount of toxin used in present study was 6.25IU which 
is less when compared to Milind Naik et al who used 
12.5 IU 7
. 
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Discussion
Study Median
age
Sex
M/F
Site of inj. Quantity 
of Toxin
Lagophth
almos
Height of 
Palp.app
Adams et 
al
NA 45.85/54.
15
Belly of 
LPS
NA NA NA
Kirkness
et al
NA NA Belly of 
LPS
NA NA NA
Ellis 
Daniel et 
al
NA NA Belly of 
LPS
NA NA NA
Milind
naik et al
30 Belly of 
LPS
12.5 units NA From 
9mm -
2mm
Our study 40 46/54 Ant.surfac
e of Tarsus
6 units 3.5 mm From 9.5-
2mm
 
CONCLUSION:  
Injection of Botulinum toxin A is safe method to achieve 
temporary ptosis by chemo-denervation of LPS. Action 
of Botox remains for up to 8 weeks within which 85% of 
cases recovered from Bell’s palsy. Only 4 cases required 
2nd injection of Botox as Bell’s palsy did not recovered 
but action of Botox started wanning. This study 
concludes Injection of Botulinum toxin A is safe and 
effective in protecting cornea and healing exposure 
keratopathy in the cases of idiopathic Bell ’s palsy. 
Note: Financial interest nil.   
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